Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG News Story

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapMomentum Trap

Brief: Brain Q1 Adjusted EBITDA Improved By EUR 1.3 Mln To EUR 0.0 Mln

Feb 28 (Reuters) - BRAIN Biotechnology Research and Information Network AG  BNNn.DE :
    * Q1 ADJUSTED EBITDA ALSO IMPROVED SIGNIFICANTLY BY EUR 1.3 MILLION TO EUR 0.0 MILLION
    * Q1 TOTAL OPERATING PERFORMANCE WAS EUR 9.9 MILLION COMPARED WITH EUR 6.0 MILLION YEAR AGO
    * CONFIDENT THAT WE WILL ACHIEVE OUR GOAL OF A DOUBLE-DIGIT INCREASE IN TOTAL OPERATING
PERFORMANCE IN 2018/19 FINANCIAL YEAR
    * IN 2018/19 FINANCIAL YEAR, MAIN FOCUS OF BRAIN GROUP IS ON ORGANIC GROWTH

Source text for Eikon:  ID:nEQ7sXcrna 
Further company coverage:  BNNn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on BRAIN Biotech AG

See all news